Newsroom

Newsroom

Featured News

Date Title and Summary
Toggle Summary Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision
Additional Detail in Patients Age 50 or Younger Presented Today in Oral Session at 2019 American Society of Clinical Oncology ( ASCO ) Annual Meeting TAILORx Continues to Elevate Oncotype DX ® to a New Global Standard with Increasing Utilization and Reimbursement REDWOOD CITY, Calif.
Toggle Summary Updated ASCO Guidelines Establish TAILORx-defined Cutoffs for Determining Chemotherapy Benefit with the Oncotype DX Breast Recurrence Score® Test in Node-negative Breast Cancer
New ASCO Recommendations Increase Proportion of Women Who Can Be Spared Chemotherapy Based on Landmark TAILORx and NSABP B-20 Randomized Clinical Trials Additional Secondary Analysis of TAILORx Trial to be Presented at ASCO Annual Meeting Today REDWOOD CITY, Calif.
Toggle Summary Oncotype DX® Genomic Prostate Score® Established as First Genomic Test with Prospective Validation for Predicting Adverse Pathology in Newly Diagnosed Patients
Results, Published in Urology, Represent First Prospective Validation of Critical Endpoint to Identify Patients for Active Surveillance REDWOOD CITY, Calif. , Feb. 5, 2019 /PRNewswire/ --  Genomic Health, Inc . (Nasdaq: GHDX) today announced the publication of results from a multi-center,
Toggle Summary Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes
Pioneering Precision Medicine While Saving Healthcare Costs REDWOOD CITY, Calif. , Jan. 7, 2019 /PRNewswire/ --  Genomic Health , Inc.  (NASDAQ: GHDX) today announced that, in collaboration with physicians around the world, it has delivered more than 1 million Oncotype DX ® tests to cancer patients

Latest Press Releases

Date Title and Summary
Toggle Summary Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision
Additional Detail in Patients Age 50 or Younger Presented Today in Oral Session at 2019 American Society of Clinical Oncology ( ASCO ) Annual Meeting TAILORx Continues to Elevate Oncotype DX ® to a New Global Standard with Increasing Utilization and Reimbursement REDWOOD CITY, Calif.
Toggle Summary Updated ASCO Guidelines Establish TAILORx-defined Cutoffs for Determining Chemotherapy Benefit with the Oncotype DX Breast Recurrence Score® Test in Node-negative Breast Cancer
New ASCO Recommendations Increase Proportion of Women Who Can Be Spared Chemotherapy Based on Landmark TAILORx and NSABP B-20 Randomized Clinical Trials Additional Secondary Analysis of TAILORx Trial to be Presented at ASCO Annual Meeting Today REDWOOD CITY, Calif.
Toggle Summary Genomic Health to Present at the Jefferies 2019 Healthcare Conference
REDWOOD CITY, Calif. , May 29, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that management will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, 2019 at 2 p.m. Eastern Time . To access the live and subsequently archived webcast
Toggle Summary Genomic Health Reports First Quarter 2019 Financial Results and Recent Business Progress
Delivered $108.8M in Revenue and Growth of 17.4 Percent Achieved Significant Revenue Growth for All Key Product Areas Reported $13.0M in Profit and EPS of $0.34 Per Share on a Diluted Basis REDWOOD CITY, Calif. , May 7, 2019 /PRNewswire/ --  Genomic Health, Inc.  (NASDAQ: GHDX) today reported

Patient & Physician Stories

 

 
 

Your Prostate, Your Decision: A Patient's Perspective

1559 views 09/24/2014

Watch the Video

Do You Know Your Oncotype DX Score?

174 views 09/29/2015

Watch the Video

Oncotype DX DCIS Breast Cancer Score: Amy's Story

8370 views 07/17/2013

Watch the Video

An Oncotype DX Breast Cancer Treatment Story from Mexico (MX)

644 views 11/13/2012

Watch the Video

Dr. Peter Carroll on the Validation of the Oncotype DX Prostate Cancer Test

299 views 12/08/2015

Watch the Video

Dr. Joseph Sparano on the Necessity of Oncotype DX Genomic Testing in Breast Cancer

164 views 12/08/2015

Watch the Video

 

Social Media

Learn About the Oncotype DX Prostate Cancer Test

13600 views 05/04/2013

Watch the Video

Genomic Health and Oncotype IQ – Delivering Precision Medicine

67 views 09/06/2018

Watch the Video

Oncotype DX AR-V7 Nucleus Detect test

528 views 08/10/2018

Watch the Video